Dr. Philip Abraham Kovoor - NPI #1578714424

Medical Oncologist located in Plano, TX

Texas Plano Medical Oncology Dr. Philip Abraham Kovoor Information


Dr. Philip Abraham Kovoor is a male Medical Oncologist (taxonomy code 207RX0202X) located in Plano, Texas. Dr. Philip Abraham Kovoor primarily specializes in Medical Oncology but also specializes in and Internal Medicine. Dr. Philip Abraham Kovoor's NPI Number is #1578714424 and has been listed in the NPI registry for 10 years. Dr. Philip Abraham Kovoor's practice location is listed as: 4708 Alliance Blvd Suite 150 Plano, TX 75093-5340 and can be reached via phone at (972) 596-7801.

Medical Oncology Taxonomy

The taxonomy code for Dr. Philip Abraham Kovoor's main specialty, Medical Oncology, is 207RX0202X. An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.



Be the first to rate Dr. Kovoor

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1578714424
 Phone (972) 596-7801
 Fax (972) 596-9307
4708 Alliance Blvd
Suite 150
Plano, TX 75093-5340
 Gender M
 Website Not provided
  • Internal Medicine (TX)
  • Medical Oncology (TX)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 9/16/2010
 Added 10/8/2008
 Viewed on 3/18/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.